EN
HI
Dr Reddy's Laboratories Chart
Dr Reddy's Laboratories. Share Key Metrics
Volume
9.65 L
Market Cap
107994.46 CR
LTQ@LTP
1@1293.90
ATP
1297.7
Var Margin
12.96 %
Circuit Range
1176.9-1438.3
Delivery %
50.6 %
Value
125.22 CR
ASM/GSM
No
Market Lot
1
Summary
Dr Reddy's Laboratories. share price stands at ₹1293.9 at 8 May, 2026 | 15:48. The stock Dr Reddy's Laboratories. intraday movement has stayed between ₹1290.00 and ₹1310.20, while on a 52-week basis it has fluctuated from ₹1129.40 to ₹1379.70.
In terms of trading activity, Dr Reddy's Laboratories. has recorded a volume of 964903 shares. The Dr Reddy's Laboratories. has a market cap of ₹834643020. The stock’s Average Traded Price (ATP) stands at ₹129770, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 129390.
The Dr Reddy's Laboratories. operates within a circuit range of ₹1176.9-1438.3 – ₹1176.9-1438.3, with a Value of ₹125.22 CR. The Delivery Percentage for the day is 50.6%. Additionally, Dr Reddy's Laboratories. currently falls under the No framework, and trades with a market lot size of 1.
Dr Reddy's Laboratories. Fundamentals
View MoreP/E Ratio
19.38
P/B Ratio
2.9
Div. Yield
0.62
Sector P/E
68.46
Sector P/B
3.55
Sec. Div. Yield
0.57
Dr Reddy's Laboratories. Resistance and Support
Pivot 1306.87
Resistance
First Resistance
1316.44
Second Resistance
1325.27
Third Resistance
1334.84
Support
First Support
1298.04
Second Support
1288.47
Third Support
1279.64
Dr Reddy's Laboratories. Futures & Options
Dr Reddy's Laboratories. Option Chain
View Price, OI, Greeks & More...
26MAY26
1292.50
-10.40 (0.80%)
30JUN26
1293.00
-9.60 (0.74%)
28JUL26
1293.00
-3.00 (0.23%)
DRREDDY|26MAY26 CE 1290.00
37.30
-7.3 (-16.37%)
DRREDDY|26MAY26 PE 1300.00
40.2
4.2 (11.67%)
Dr Reddy's Laboratories. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-12 | Audited Results |
| 2026-01-21 | Quarterly Results |
| 2025-10-24 | Quarterly Results |
| 2025-07-23 | Quarterly Results |
| 2025-05-09 | Audited Results |
| 2025-01-23 | Quarterly Results |
Dr Reddy's Laboratories. News
Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Dr. Reddy's Laboratories received Health Canada approval for its generic Semaglutide Injection, authorizing its commercialization, sale, and distribution in Canada. This marks a significant milestone as it's the first company to obtain such authorization in Canada.
Apr 29 2026 09:04:00
Dr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation For Recommending Final Dividend, If Any, For The Financial Year 2025-26
Dr. Reddy's Laboratories board will consider recommending a final dividend for FY 2025-26. This decision will be made during an upcoming board meeting, following a prior intimation from March 23, 2026.
Apr 16 2026 15:04:00
About Dr Reddy's Laboratories.
NSE : 881
BSE : 500124
ISIN : INE089A01031
Dr Reddy's Laboratories. Management
| Name | Position |
|---|---|
| K Randhir Singh | Company Secretary, Compliance Officer and Head-CSR |
| K Satish Reddy | Chairman |
Dr Reddy's Laboratories. Similar Stocks
Divi's Laboratories Ltd.
6710.50
8.00 (0.12%)
Torrent Pharmaceuticals Ltd.
4380.80
18.10 (0.41%)
Lupin Ltd.
2379.50
-80.60 (3.28%)
Apollo Hospitals Enterprise Ltd.
8097.00
260.00 (3.32%)
Cipla Ltd.
1347.00
-15.30 (1.12%)
Max Healthcare Institute Ltd.
1012.50
-2.80 (0.28%)
Mankind Pharma Ltd.
2430.80
55.60 (2.34%)
Zydus Lifesciences Ltd.
940.05
-0.25 (0.03%)
Lenskart Solutions Ltd.
489.25
1.50 (0.31%)
Aurobindo Pharma Ltd.
1487.30
8.60 (0.58%)
Dr Reddy's Laboratories. FAQs
The Buying Price of Dr Reddy's Laboratories. share is 1293.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Dr Reddy's Laboratories. stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dr Reddy's Laboratories., choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Dr Reddy's Laboratories. shares is 19.38. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Dr Reddy's Laboratories. shares is 2.9. Useful to assess the stock's value relative to its book value.
To assess Dr Reddy's Laboratories.’s valuation compare Sector P/E, P/B which are 68.46 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Dr Reddy's Laboratories. is 107994.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Dr Reddy's Laboratories. share price is 1379.70 & 1129.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Dr Reddy's Laboratories. belongs to the Healthcare sector.
